Interestingly, 5 out of 16 SHH pathway genes showed core enrichment in FGFR1-expressed breast cancer patients using leading-edge subset method (Figure 1 and Supplementary Material ESM 8). The gene discussed is FGFR1; the disease is breast cancer.